{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "A review of Merck's handling of Vioxx suggests that actions the company took - and did not take - may have affected the health of potentially thousands of patients.", "headline": {"main": "Despite Warnings, Drug Giant Took Long Path to Vioxx Recall", "kicker": "Dangerous Data"}, "abstract": null, "print_page": null, "word_count": "4616", "_id": "5177e7d0fdc5920bc400045e", "snippet": "A review of Merck's handling of Vioxx suggests that actions the company took - and did not take - may have affected the health of potentially thousands of patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/14/business/14merck.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Recalls and Bans of Products", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Merck & Company Incorporated", "is_major": "N", "rank": "1", "name": "organizations"}], "byline": {"person": [], "original": "By THE NEW YORK TIMES", "organization": "THE NEW YORK TIMES"}, "document_type": "article", "pub_date": "2004-11-14T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Federal prosecutors and the Securities and Exchange Commission are investigating Merck & Company in connection with Vioxx, the painkiller that was withdrawn from the market in late September because it increased the risk of heart attacks in long-term users. Merck said yesterday that it had received a subpoena from the Justice Department ''requesting information related to the company's research, marketing and selling activities with respect to Vioxx.'' It said the request related to a ''federal health care investigation under criminal statutes.''", "headline": {"main": "Justice Dept. And S.E.C. Investigating Merck Drug"}, "abstract": "Justice Department and Securities and Exchange Commission are investigating Merck & Co in connection with Vioxx, painkiller that was withdrawn from market in late September because it increased risk of heart attacks in long-term users; Justice Department issues subpoena requesting information related to company's research, marketing and selling activities with respect to Vioxx; SEC has begun informal inquiry (M)", "print_page": "1", "word_count": 863, "_id": "4fd2497f8eb7c8105d7e6c8c", "snippet": "Federal prosecutors and the S.E.C. are investigating Merck in connection with its recalled pain reliever, Vioxx.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/09/business/09drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "MERCK & CO INC"}, {"name": "organizations", "value": "SECURITIES AND EXCHANGE COMMISSION"}, {"name": "organizations", "value": "MERCK & COMPANY INCORPORATED"}, {"name": "subject", "value": "SUBPOENAS"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "ARTHRITIS AND RHEUMATISM"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}, {"name": "subject", "value": "VIOXX (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2004-11-09T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 2, "offset": 0, "time": 94}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}